HSAQ
Health Sciences Acquisitions Corporation 2
Set alert
13.31 0.00 0.00%
10.44 Day range 13.50
9.41 52-week range 13.80
- Open
- 10.80
- Prev close
- 13.31
- Mkt cap
- 149.23M
- Vol
- 119.61K
- Avg vol
- 70.10K
- EPS
- -0.035
- P/E
- -532.40
- Div yield
- 0.00%
More statistics
- Low
- 10.44
- High
- 13.50
- Forward P/E
- 0.00
- Beta
- 0.08
- Short ratio
- 4.62
- Inst. own
- 52.23%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.06
- 200-d avg
- 9.96
- 1y target
- 0.00
Key statistics
- Market cap
- 149.23M
- Enterprise value
- 119.01M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.035
- Beta
- 0.08
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -424.20K
- Total cash
- 175.16K
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 11.21M
- Short % of float
- 10.84%
- 50-day average
- 10.06
- 200-day average
- 9.96
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on HSAQ — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HSAC 2 HOLDINGS, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 5, 2020 | 4,360,960 |
| LEE ALICE | Officer and Treasurer | Purchase | Aug 3, 2020 | 10,000 |
| SIROTA STEPHANIE A | Officer | Purchase | Aug 3, 2020 | 0 |
| WONG RODERICK | Chief Executive Officer | Purchase | Jan 23, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 8.92% | 1,000,000 | 13.31M | Sep 29, 2022 |
| Blackrock Inc. | 7.05% | 790,436 | 10.52M | Sep 29, 2022 |
| Price (T.Rowe) Associates Inc | 6.46% | 724,565 | 9.64M | Sep 29, 2022 |
| RA Capital Management, L.P. | 5.44% | 610,283 | 8.12M | Sep 29, 2022 |
| Boxer Capital, LLC | 3.57% | 400,000 | 5.32M | Sep 29, 2022 |
| EcoR1 Capital, LLC | 3.57% | 400,000 | 5.32M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Health Sciences Fund | 5.36% | 600,927 | 8.00M | Sep 29, 2022 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 2.34% | 262,308 | 3.49M | Nov 29, 2022 |
| BlackRock Health Sciences Trust II | 2.08% | 233,344 | 3.11M | Sep 29, 2022 |
| Price (T.Rowe) Equity Series Inc.-Health Sciences Portf | 0.28% | 30,999 | 412.60K | Sep 29, 2022 |
| John Hancock Fds II-Health Sciences Fund | 0.17% | 19,166 | 255.10K | Aug 30, 2022 |
| John Hancock Var Ins Tr-Health Sciences Tr | 0.12% | 13,354 | 177.74K | Sep 29, 2022 |